ask="6.50"
ask_size="3000"
average_daily_volume="1446740"
bid="5.99"
bid_size="1000"
book_value="0.21"
change="+0.14"
change_from_200_day_moving_average="0.74"
change_from_50_day_moving_average="0.29"
change_from_52_week_high="-1.58"
change_From_52_week_low="3.42"
change_in_percent="+2.30%"
close="6.22"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.56"
ebitda="-113.37M"
eps_estimate_current_year="-1.40"
eps_estimate_next_quarter="-0.20"
eps_estimate_next_year="-0.59"
ex_dividend_date="N/A"
float_shares="71325000"
high="6.28"
high_52_weeks="7.80"
last_trade_date="1/4/2017"
last_trade_price="6.22"
last_trade_size="86577"
last_trade_time="4:00pm"
low="5.93"
low_52_weeks="2.80"
market_capitalization="659.07M"
moving_average_200_day="5.48"
moving_average_50_day="5.93"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="6.86"
open="6.14"
pe_ratio="N/A"
peg_ratio="-0.04"
percent_change_from_200_day_moving_average="+13.46%"
percent_change_from_50_day_moving_average="+4.90%"
percent_change_from_52_week_high="-20.26%"
percent_change_from_52_week_low="+122.14%"
previous_close="6.08"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="29.23"
price_per_sales="22.82"
revenue="28.23M"
shares_outstanding="105960000"
short_ratio="14.92"
stock_exchange="NCM"
symbol="KERX"
volume="1395133"
weeks_range_52="2.80 - 7.80"
